SCHEMBL563403

SCHEMBL563403

COP(=O)(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
POLB P06746 2/20 0.50
LMNA P02545 1/20 0.50
HPGD P15428 1/20 0.48
LAP3 P28838 1/20 0.46
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 1/20 0.42
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
EPHX2 P34913 1/20 0.39
LTA4H P09960 1/20 0.39
TP53 P04637 1/20 0.39
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11780922 0.88 HPGD (0.57) MEN1KMT2APOLBLMNAHPGD
SCHEMBL563700 0.82 HPGD (0.48) MEN1KMT2APOLBLMNAHPGD
SCHEMBL20826937 0.81 HPGD (0.52) MEN1KMT2ALMNAHPGDHTT
SCHEMBL11605919 0.80 HPGD (0.47) MEN1KMT2APOLBLMNAHPGD
SCHEMBL563856 0.78 NPSR1 (0.50) MEN1KMT2APOLBHPGDTSHR
SCHEMBL232550 0.78 LAP3 (0.51) MEN1KMT2APOLBLMNAHPGD
SCHEMBL15699773 0.78 LAP3 (0.47) MEN1KMT2APOLBLMNAHPGD
SCHEMBL28883513 0.77 HPGD (0.54) MEN1KMT2AHPGDLAP3TSHR
SCHEMBL27599195 0.77 HPGD (0.48) MEN1KMT2ALMNAHPGDHTT
SCHEMBL27617677 0.77 HPGD (0.48) MEN1KMT2ALMNAHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2957514-B1 MULTI-LAYER BOTTLE AND METHOD FOR PRODUCING SAME MITSUBISHI GAS CHEMICAL CO (JP) 2021-08-04 EP disclosed
US-10144548-B2 Multi-layer bottle and method for producing same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2018-12-04 US disclosed
US-20160001914-A1 MULTI-LAYER BOTTLE AND METHOD FOR PRODUCING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2016-01-07 US disclosed
EP-2957514-A1 MULTI-LAYER BOTTLE AND METHOD FOR PRODUCING SAME Mitsubishi Gas Chemical Company, Inc. (JP) 2015-12-23 EP disclosed
CN-103122129-A Polymer blends with improved notched impact strength EASTMAN CHEM CO 2013-05-29 CN disclosed
CN-1898325-B Polymer blends with improved notched impact strength EASTMAN CHEM CO 2013-03-06 CN disclosed
US-20120034480-A1 Catalyst for producing polyesters and polyester resin composition SAKAMOTO JUN (JP) 2012-02-09 US disclosed
US-20100209735-A1 Polyester resin compositions, polyester film, and magnetic recording medium YOSHIMURA HITOSHI 2010-08-19 US disclosed
US-7709594-B2 Polyester resin compositions, catalyst for polyester production, polyester film, and magnetic recording medium TORAY INDUSTRIES, INC. (JP) 2010-05-04 US disclosed
CN-1898325-A Polymer blends with improved notched impact strength EASTMAN CHEM CO (US) 2007-01-17 CN disclosed
US-20050239929-A1 Polyester resin compositions, catalyst for polyester production, polyester film, and magnetic recording medium TORAY INDUSTRIES, INC. (JP) 2005-10-27 US disclosed
EP-1550683-A1 POLYESTER RESIN COMPOSITIONS, CATALYST FOR POLYESTER PRODUCTION, POLYESTER FILM, AND MAGNETIC RECORDING MEDIUM TORAY INDUSTRIES, INC. (JP) 2005-07-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120034480-A1 Catalyst for producing polyesters and polyester resin composition PUF60, RPS24, SRP54 MEN1 2460/4885KMT2A 1503/4885POLB 988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.